Literature DB >> 10411631

Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist.

A Kikonyogo1, D P Abriola, M Dryjanski, R Pietruszko.   

Abstract

Low concentrations of citral (3,7-dimethyl-2,6-octadienal), an inhibitor of retinoic acid biosynthesis, inhibited E1, E2 and E3 isozymes of human aldehyde dehydrogenase (EC1.2.1.3). The inhibition was reversible on dilution and upon long incubation in the presence of NAD+; it occurred with simultaneous formation of NADH and of geranic acid. Thus, citral is an inhibitor and also a substrate. Km values for citral were 4 microM for E1, 1 microM for E2 and 0.1 microM for E3; Vmax values were highest for E1 (73 nmol x min-1 x mg-1), intermediate for E2 (17 nmol x min-1 x mg-1) and lowest (0.07 nmol x min-1 x mg-1) for the E3 isozyme. Citral is a 1 : 2 mixture of isomers: cis isomer neral and trans isomer, geranial; the latter structurally resembles physiologically important retinoids. Both were utilized by all three isozymes; a preference for the trans isomer, geranial, was observed by HPLC and by enzyme kinetics. With the E1 isozyme, both geranial and neral, and with the E2 isozyme, only neral obeyed Michaelis-Menten kinetics. With the E2 isozyme and geranial sigmoidal saturation curves were observed with S0.5 of approximately 50 nM; the n-values of 2-2.5 indicated positive cooperativity. Geranial was a better substrate and a better inhibitor than neral. The low Vmax, which appeared to be controlled by either the slow formation, or decomposition via the hydride transfer, of the thiohemiacetal reaction intermediate, makes citral an excellent inhibitor whose selectivity is enhanced by low Km values. The Vmax for citral with the E1 isozyme was higher than those of the E2 and E3 isozymes which explains its fast recovery following inhibition by citral and suggests that E1 may be the enzyme involved in vivo citral metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411631     DOI: 10.1046/j.1432-1327.1999.00415.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Methoprene photolytic compounds disrupt zebrafish development, producing phenocopies of mutants in the sonic hedgehog signaling pathway.

Authors:  Denice G Smith; Claudia Wilburn; Robert A McCarthy
Journal:  Mar Biotechnol (NY)       Date:  2003 Mar-Apr       Impact factor: 3.619

2.  Retinoid receptors trigger neuritogenesis in retinal degenerations.

Authors:  Yanhua Lin; Bryan W Jones; Aihua Liu; James F Tucker; Kevin Rapp; Ling Luo; Wolfgang Baehr; Paul S Bernstein; Carl B Watt; Jia-Hui Yang; Marguerite V Shaw; Robert E Marc
Journal:  FASEB J       Date:  2011-09-22       Impact factor: 5.191

3.  Transient retinoic acid signaling confers anterior-posterior polarity to the inner ear.

Authors:  Jinwoong Bok; Steven Raft; Kyoung-Ah Kong; Soo Kyung Koo; Ursula C Dräger; Doris K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

4.  CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Authors:  Joseph A Micucci; Wanda S Layman; Elizabeth A Hurd; Ethan D Sperry; Sophia F Frank; Mark A Durham; Donald L Swiderski; Jennifer M Skidmore; Peter C Scacheri; Yehoash Raphael; Donna M Martin
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

5.  Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.

Authors:  Angelica R Harper; Anh T Le; Timothy Mather; Anthony Burgett; William Berry; Jody A Summers
Journal:  Bioorg Med Chem       Date:  2018-10-24       Impact factor: 3.641

6.  Retinoic acid signalling regulates the development of tonotopically patterned hair cells in the chicken cochlea.

Authors:  Benjamin R Thiede; Zoë F Mann; Weise Chang; Yuan-Chieh Ku; Yena K Son; Michael Lovett; Matthew W Kelley; Jeffrey T Corwin
Journal:  Nat Commun       Date:  2014-05-20       Impact factor: 14.919

Review 7.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

8.  Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes.

Authors:  Tianlin Xiao; Mohammad Shoeb; M Saeed Siddiqui; Min Zhang; Kota V Ramana; Satish K Srivastava; Vasilis Vasiliou; Naseem H Ansari
Journal:  J Toxicol Environ Health A       Date:  2009

9.  Retinoic acid biosynthesis catalyzed by retinal dehydrogenases relies on a rate-limiting conformational transition associated with substrate recognition.

Authors:  Raphaël Bchini; Vasilis Vasiliou; Guy Branlant; François Talfournier; Sophie Rahuel-Clermont
Journal:  Chem Biol Interact       Date:  2012-12-07       Impact factor: 5.192

10.  Retinaldehyde represses adipogenesis and diet-induced obesity.

Authors:  Ouliana Ziouzenkova; Gabriela Orasanu; Molly Sharlach; Taro E Akiyama; Joel P Berger; Jason Viereck; James A Hamilton; Guangwen Tang; Gregory G Dolnikowski; Silke Vogel; Gregg Duester; Jorge Plutzky
Journal:  Nat Med       Date:  2007-05-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.